AMRN ANDA lit - Appellate court affirms
Just one day after oral arguments, in a non-precedential decision without a written opinion, the 3-judge panel unanimously affirmed the district court ruling the AMRN patents are invalid. AMRN's next steps would be to attempt to get a review by the full appellate court or a Supreme Court review. However, both of these are unlikely to be granted for the vast majority of cases, and my initial speculation is that this is even more true for a case decided without a written opinion. We will look into this further shortly. As we indicated yesterday, we plan to provide information on other patent opportunities for AMRN against the generics this month.
#AMRN, #Vascepa, #Hikma, #icosapent_ethyl, #ANDA_litigation, #patent_litigation
13 Views